Cannabis Medical Solutions increases authorized common stock shares to 500,000,000

NewsGuard 100/100 Score

Cannabis Medical Solutions Inc. (www.cannabismedsolutions.com) (OTCBB:CMSI), a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts and services, today announced that its board of directors has approved a resolution authorizing an increase in the number of authorized shares of the Corporation's common stock from 250,000,000 to 500,000,000. The Company's board of directors and majority shareholders have also voted for an issuance of a stock dividend to each shareholder of CMSI. Pursuant to the resolutions, holders of the company's common stock will each receive an additional nine shares of common stock for each share they own of the record date set for May 14, 2010. Distribution of the dividend will begin on June 1, 2010.

"The Board of Directors believes that an increase in the number of shares of authorized common stock and stock dividend will benefit CMSI and our stockholders by giving us needed flexibility in our corporate planning and in responding to developments in our business, including possible acquisition transactions, financings, stock dividends and other general corporate purposes,"  stated Kyle Gotshalk, CEO of Cannabis Medical Solutions.

SOURCE Cannabis Medical Solutions Inc.

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Heightened risk of adverse neonatal outcomes from prenatal exposure to both cannabis and nicotine